US FDA grants clearance for the use of Verdeca’s HB4 stress-tolerant soybeans in human food

8cbd8b5a-716e-45e1-8dc2-75e602e028c8articleimage.jpg

11 Aug 2017 --- Arcadia Biosciences Inc. and Bioceres S.A. have announced that the US Food and Drug Administration (FDA) has completed its full review of the safety evaluation for HB4 soybeans, produced by their joint venture, Verdeca. The FDA’s notice to Verdeca allows products derived from HB4 soybeans to be used commercially in human food and animal feed.

The US FDA uses its Biotechnology Notice process to review and assess safety data provided by companies developing new plant varieties using advanced breeding technologies. The data provided to the FDA is consistent with international regulatory requirements for genetically modified crops and will be used by Verdeca and its global partners for future regulatory submissions, the companies report.

Verdeca’s HB4 soybeans have undergone extensive testing, including multi-location field trials in Argentina and the US and multiple regulatory field trials. The results of these trials demonstrate that the HB4 trait can provide yield advantages under stress conditions – including drought and low-water conditions – found in several soybean production areas.

“The HB4 gene holds great promise for bringing better yield stability to agriculture in areas that experience chronic water stress problems,” says Raj Ketkar, President and CEO of Arcadia Biosciences. “Our combined efforts aim to create significant value for soybean growers by increasing the productivity and sustainability of this important protein crop in the face of global climate challenges.”

“The FDA is one of the most prestigious regulatory agencies in the world, and its opinions are of reference to regulators everywhere,” says Federico Trucco, CEO of Bioceres. “In a way, this FDA clearance testifies to the quality standards implemented in HB4 product development and safety evaluations. We hope this decision will help expedite international regulatory clearances for HB4 soybeans, and bring us closer to the much-anticipated launch of this unique technology.”

Completion of the FDA’s review is another key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The trait has already been approved in Argentina by the Ministry of Agriculture, Livestock and Fisheries.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Regulatory News

Oleic acid CHD claims success: US FDA approves qualified claim petition on high level foods 

20 Nov 2018 --- The US Food and Drug Administration (FDA) has responded positively to a petition for a new qualified health claim for edible oils containing oleic acid. As a result, products with an oleic acid content upward of 70 percent, such as certain olive, canola and sunflower oils, can be labeled as carrying cardiovascular benefits, but only when replacing heart-damaging saturated fat.

Health & Nutrition News

US study links soy-based formula milk to increased risk of menstrual pain in women

12 Nov 2018 --- Women who were fed soy-based formula milk when they were babies have an increased risk of suffering from severe pain during their menstrual bleeds, according to the latest study to investigate the link.

Packaging & Technology News

Instant-mix cap: Karma-Aptar collaboration targets personalized, fortified nutrition trend

12 Nov 2018 --- Creators of the Karma Push Cap Technology, Karma, have formed a collaboration with Aptar Food + Beverage, a global specialist in dispensing, sealing and active packaging solutions, to deliver instant-mix technology to a range of market segments focused on the rising trend of personalized, fortified nutrition. The collaboration believes that the cap has the potential to extend beyond beverage into other industries, including medical and pharmaceutical.

Health & Nutrition News

“Confronting” Australian public campaign to highlight impact of sugary drinks on obesity and cancer

29 Oct 2018 --- Cancer Council Victoria has launched a “confronting” public awareness campaign to inform Australians about the link between obesity and 13 types of cancer. The campaign seeks to address the fact that nearly two-thirds of Australians are overweight or obese, according to the Australian Institute of Health and Welfare, and that one crucial way to lose weight is to cut sugary drinks from the diet. The “gruesome” images of the campaign have been likened to the public health approach used to warn smokers of the dangers of tobacco.

Health & Nutrition News

Healthy sweetness: Amai Proteins CEO on sweet protein potential

26 Oct 2018 --- The food industry is undergoing massive, disruptive changes, with innovative start-ups in a range of disciplines vying to tackle global nutrition issues. One of these, Amai Proteins, is aiming to disrupt the global sweetening market by offering sweet proteins that are fit for mass food production. NutritionInsight spoke with Amai Proteins CEO and Founder Dr. Ilan Samish at Future Food-Tech in London.

More Articles
URL : http://www.nutritioninsight.com:80/news/us-fda-grants-clearance-for-the-use-of-verdecas-hb4-stress-tolerant-soybeans-in-human-food.html